SRTA — Strata Critical Medical Balance Sheet
0.000.00%
- $360.14m
- $298.90m
- $197.14m
Annual balance sheet for Strata Critical Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 September 30th | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | PRESS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 282 | 194 | 166 | 127 | 61.2 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 5.55 | 10.9 | 21 | 21.6 | 40 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 295 | 218 | 206 | 161 | 126 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.76 | 19.7 | 26.4 | 39.8 | 39.6 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 336 | 325 | 295 | 257 | 325 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 12.8 | 26.6 | 35.5 | 22.7 | 19.8 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 44.5 | 50.5 | 60.6 | 34.7 | 46.4 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 291 | 274 | 234 | 222 | 279 |
| Total Liabilities & Shareholders' Equity | 336 | 325 | 295 | 257 | 325 |
| Total Common Shares Outstanding |